Matches in Nanopublications for { ?s ?p "Currently, there are FDA-approved therapies that attenuate the dysregulated inflammation that occurs in COVID-19 patients, such as dexamethasone or other corticosteroids and IL-6 inhibitors, including sarilumab, tocilizumab, and siltuximab." ?g. }
Showing items 1 to 1 of
1
with 100 items per page.